These data are in agreement with the barrier-protective effects of HDAC6 inhibitor tubacin A, which prevented endothelial barrier dysfunction in response to thrombin [67], TNFα, and LPS [68] in endothelial cells and the mice model of acute lung injury (ALI). This evidence concerns the gene HDAC6 and acute respiratory distress syndrome.